共 238 条
[1]
Mandell LA(2007)Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults Clin Infect Dis 44 S27-72
[2]
Wunderink RG(2004)Risk factors of treatment failure in community acquired pneumonia: implications for disease outcome Thorax 59 960-965
[3]
Anzueto A(2017)Deaths: leading causes for 2015 Natl Vital Stat Rep 66 1-76
[4]
Menéndez R(2013)The incidence rate and economic burden of community-acquired pneumonia in a working-age population Am Health Drug Benefits 6 494-503
[5]
Torres A(2010)Burden of community-acquired pneumonia in North American adults Postgrad Med 122 130-141
[6]
Zalacaín R(2014)Community-acquired pneumonia N Engl J Med 371 1619-1628
[7]
Aspa J(2009)Risk factors for community acquired pneumonia in immunocompetent seniors J Am Geriatr Soc 57 882-888
[8]
Martín Villasclaras JJ(2015)Direct medical costs and utilization of health care services to treat pneumonia in the United States: an analysis of the 2007–2011 Medical Expenditure Panel Survey Clin Ther 37 1466-76.e1
[9]
Borderías L(2017)Biomarkers in pediatric community acquired pneumonia Int J Mol Sci 18 447-1914
[10]
Benítez Moya JM(2003)Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17 J Biol Chem 278 1910-240